# Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

> **NCT02864316** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 6 (actual)

## Conditions studied

- Solid Tumors Induced by Prior Radiation Exposure

## Interventions

- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT02864316
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12
- **Primary completion:** 2018-08
- **Final completion:** 2018-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864316, "Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02864316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*